Form 4: Xometry Director Sells Shares After Option Exercise

Xometry Director Emily Rollins executed a Rule 10b5-1 plan, exercising stock options and subsequently selling a portion of her Class A Common Stock.

Summary

• Emily Rollins, a Director of Xometry, Inc., engaged in transactions involving Class A Common Stock on January 2, 2026.
• Rollins exercised stock options to acquire 1,000 shares of Class A Common Stock at an exercise price of $12.32 per share.
• Following the option exercise, Rollins sold 275 shares at a weighted average price of $60.895 per share, with prices ranging from $60.24 to $61.235.
• An additional 725 shares were sold at a weighted average price of $62.229 per share, with prices ranging from $61.61 to $62.59.
• All reported transactions were executed automatically pursuant to a Rule 10b5-1 trading plan adopted at least 90 days prior to the trading date.
• After these transactions, Rollins beneficially owns 11,455 shares of Class A Common Stock directly.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions executed under a pre-established Rule 10b5-1 trading plan, which typically does not indicate a change in sentiment regarding the company's future prospects. The director realized a profit from option exercise and subsequent sale.

Positives

• The director realized a significant profit by exercising options at $12.32 and selling shares at prices averaging over $60.
• Transactions were conducted under a Rule 10b5-1 plan, indicating pre-planning and reducing concerns about opportunistic insider trading.

Negatives

• A director selling shares, even under a 10b5-1 plan, could be perceived by some investors as a lack of conviction, though this is often for personal financial planning.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Management Comments

• The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

Industry Context

This filing reports an individual insider transaction and does not provide information relevant to broader industry trends or competitive analysis.

Stakeholder Impact

• Shareholders: The sale of shares by a director, even under a 10b5-1 plan, might be viewed with slight caution, but the pre-planned nature mitigates concerns about opportunistic selling.

Key Dates

Keywords

Xometry, XMTR, Form 4, insider trading, stock options, Rule 10b5-1, director, share sale